Aradhna Saklani*, D. C. Singh and Rishi Arya


Ama is an unprocessed product of digestion formed due to agnimandya (poor digestive fire) which is the causative factor for the disease Amavata. Ama does not reveal itself directly physically but expresses itself through the effect it has on the body. Ama (undigested food) hinders the physiological channels of the body, it slows down the metabolism, impedes the supply of produced metabolites and toxins that are produced which results in increased production of Ama. Now as the level of tissue has been penetrated, our immune system starts to attack the affected cells. This causes the inflammation or allergic reaction that can lead to autoimmune disease. Ama then combines with Vata and lodges in the joints and causes amavata. Erand (Ricinus communis) can be used as a complete treatment in Amavata internally as well as externally. Single drug is cost effective, economical and easy to use. Amavata is a chronic in- flammatory disease and is a kaphaavrit vata vyadi. Erand is said to be kaphavata hanti and its Ras panchak breaks its pathogenesis at every step. Due to its ushna virya it works both on kapha and vata. Due to sukshma guna, it can enter minute channels of the body and due to its bhedniya, svedopug guna has mentioned by acharya charak. It causes the loosening of dosha-dushya samurchna and causes the bhedan of the samurchna. It has angmardprashman property too, which relieves the pain in Amavata, which is a major cry of the patients of Amavata. Due to its snigdha Guna it decreases the stiffness of the joint and increases the mobility of the joint.

Keywords: Erand, Ama, Amavata, Kaphaavrit vata, Ras panchak.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    AUGUST 2020 Issue has been successfully launched on 1 August 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction